Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein (RPCB2131)
- SKU:
- RPCB2131
- Size:
- 100 μg
- Reactivity:
- SARS-COV-2
- Tag:
- C-hFc
- Expression Host:
- HEK293 cells
- Calculated MW:
- 158.3 kDa
- Observed MW:
- 230-250 kDa
- Application Area:
- Infectious Disease
Description
Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein
The Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein is a high-quality recombinant protein produced for advanced research applications in molecular biology and biotechnology. This protein serves as a critical reagent in various experimental contexts, including functional studies, binding assays, and therapeutic development programs, providing researchers with a standardized and reliable tool for investigating protein function and interactions.
This product (SKU: RPCB2131) is produced using HEK293 cells and features a C-hFc tag for convenient detection and purification. The protein exhibits a calculated molecular weight of 158.3 kDa with an observed molecular weight of 230-250 kDa under denaturing conditions, achieving ≥ 95 % as determined by Tris-Bis PAGE;≥ 95 % as determined by HPLC.. Functional bioactivity has been validated through rigorous quality control assays, confirming its suitability for demanding research applications.
Key Features
| High Purity by Affinity Chromatography | |
| Mammalian & Bacterial Expression Systems | |
| High lot-to-lot consistency via strict QC |
| Product Name: | Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein |
| SKU: | RPCB2131 |
| Size: | 100 μg |
| Reactivity: | SARS-COV-2 |
| Synonyms: | S protein, Spike glycoprotein, S glycoprotein, COVID-19 |
| Tag: | C-hFc |
| Expression Host: | HEK293 cells |
| Calculated MW: | 158.3 kDa |
| Observed MW: | 230-250 kDa |
| Gene ID: | 43740568 |
| Protein Description: | High quality, high purity and low endotoxin recombinant Recombinant SARS-COV-2 Spike S1+S2 ECD (S-ECD) Protein (RPCB2131), tested reactivity in HEK293 cells and has been validated in SDS-PAGE.100% guaranteed. |
| Endotoxin: | < 1 EU/μg of the protein by LAL method. |
| Purity: | ≥ 95 % as determined by Tris-Bis PAGE;≥ 95 % as determined by HPLC. |
| Formulation: | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
| Bio-Activity: | Immobilized Human ACE2,His Tag at 5 μg/mL (100 μL/Well). Dose response curve for SARS-COV-2 Spike S,hFc Tag with the EC 50 of 0.9 μg/mL determined by ELISA. |
| Reconstitution: | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
| Storage: | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |

